Recombinant Adenoviral Human p53 Gene in Treatment of Malignant Pleural Effusion

NCT02429726 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Pleural Effusion

Interventions

DRUG: rAdp53
DRUG: Cisplatin
DRUG: rAdp53 plus cisplatin

Sponsor

Shenzhen SiBiono GeneTech Co.,Ltd